摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-碘苯并二氢吡喃e | 67856-45-5

中文名称
6-碘苯并二氢吡喃e
中文别名
——
英文名称
6-iodochromane
英文别名
6-iodochroman;6-iodo-3,4-dihydro-2H-chromene
6-碘苯并二氢吡喃e化学式
CAS
67856-45-5
化学式
C9H9IO
mdl
——
分子量
260.074
InChiKey
LOHYOLMVKQWFIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    296.9±29.0 °C(Predicted)
  • 密度:
    1.741±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2932999099

SDS

SDS:d79a74b1c344bfd6cf7577922c59839b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2009062289A1
    公开(公告)日:2009-05-22
    Compounds of formula I : wherein c, R2, R3, R4, R5, R6, R7 and R8 are defined herein, are useful as inhibitors of HIV replication.
    公式I的化合物:其中c、R2、R3、R4、R5、R6、R7和R8按本说明定义,可用作HIV复制的抑制剂。
  • Umpolung Strategy for Arene C−H Etherification Leading to Functionalized Chromanes Enabled by I(III) <i>N</i> ‐Ligated Hypervalent Iodine Reagents
    作者:Myriam Mikhael、Wentao Guo、Dean J. Tantillo、Sarah E. Wengryniuk
    DOI:10.1002/adsc.202100809
    日期:2021.11.9
    The direct formation of aryl C−O bonds via the intramolecular dehydrogenative coupling of a C−H bond and a pendant alcohol represents a powerful synthetic transformation. Herein, we report a method for intramolecular arene C−H etherification via an umpoled alcohol cyclization mediated by an I(III) N-HVI reagent. This approach provides access to functionalized chromane scaffolds from primary, secondary
    通过C-H键和侧醇的分子内脱氢偶联直接形成芳基C-O键代表了强大的合成转化。在此,我们报告了一种通过 I(III) N- HVI 试剂介导的 umpoled 醇环化进行分子内芳烃 C-H 醚化的方法。这种方法通过级联环化-碘盐形成从伯醇、仲醇和叔醇中获得官能化色满支架,后者为下游衍生化提供了通用的功能处理。计算研究支持通过 I(III) 配体交换初始形成 umpoled O-中间体,然后是竞争性直接和螺环化/1,2-转变途径。
  • [EN] HETEROBICYCLE-SUBSTITUTED AZOLYL BENZENE FUNGICIDES<br/>[FR] FONGICIDES D'AZOLYL BENZÈNE SUBSTITUÉ PAR HÉTÉROBICYCLE
    申请人:DU PONT
    公开号:WO2011059619A1
    公开(公告)日:2011-05-19
    Disclosed are compounds of Formula 1, including all stereoisomers, N oxides, and salts thereof, wherein Y is a 5-membered, fully or partially unsaturated heterocyclic ring containing 2-4 carbon atoms and 2-3 nitrogen atoms as ring members, the ring substituted with Z on a ring member atom connected through an adjacent single ring member atom to the ring member atom attaching the heterocyclic ring to the phenyl ring of Formula 1, and optionally further substituted with up to 2 substituents independently selected from R5 on carbon atom ring members and from R6 on nitrogen atom ring members; Z is an 8-, 9-, 10- or 11-membered fused heterobicyclic ring system containing ring members selected from carbon atoms and 1 to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, wherein up to 3 carbon atom ring members are independently selected from C(=O) and C(=S), and the sulfur atom ring members are independently selected from S(=O)u(=NR7)z, the ring system optionally substituted with substituents independently selected from R8 on carbon atom ring members and from R9 on nitrogen atom ring members; and R1, R2, R3, R4, R5, R6, R7, R8, R9, u and z are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.
    公开的是Formula 1的化合物,包括所有立体异构体、N-氧化物和盐,其中Y是一个5元的、完全或部分不饱和的杂环环,含有2-4个碳原子和2-3个氮原子作为环成员,该环在通过相邻的单环成员原子连接到将杂环环连接到Formula 1的苯环上的环成员原子上与Z取代,并且可选地进一步取代最多2个取代基,独立地从碳原子环成员上的R5和氮原子环成员上的R6中选择;Z是一个8、9、10或11元的融合杂双环环系统,其中环成员从碳原子和1到4个异原子中独立选择,这些异原子最多选择2个O、最多2个S和最多4个N原子,其中最多3个碳原子环成员独立选择自C(=O)和C(=S),硫原子环成员独立选择自S(=O)u(=NR7)z,环系统可选地取代取代基,独立地从碳原子环成员上的R8和氮原子环成员上的R9中选择;以及R1、R2、R3、R4、R5、R6、R7、R8、R9、u和z如披露中所定义。还公开了含有Formula 1的化合物的组合物以及用于控制由真菌病原体引起的植物病害的方法,包括施用本发明的化合物或组合物的有效量。
  • Transnitrilation from Dimethylmalononitrile to Aryl Grignard and Lithium Reagents: A Practical Method for Aryl Nitrile Synthesis
    作者:Jonathan T. Reeves、Christian A. Malapit、Frederic G. Buono、Kanwar P. Sidhu、Maurice A. Marsini、C. Avery Sader、Keith R. Fandrick、Carl A. Busacca、Chris H. Senanayake
    DOI:10.1021/jacs.5b06136
    日期:2015.7.29
    An electrophilic cyanation of aryl Grignard or lithium reagents, generated in situ from the corresponding aryl bromides or iodides, by a transnitrilation with dimethylmalononitrile (DMMN) was developed. DMMN is a commercially available, bench-stable solid. The transnitrilation with DMMN avoids the use of toxic reagents and transition metals and occurs under mild reaction conditions, even for extremely
    开发了芳基格氏试剂或锂试剂的亲电氰化,由相应的芳基溴化物或碘化物原位生成,通过与二甲基丙二腈 (DMMN) 进行腈基转移。DMMN 是市售的、工作台稳定的固体。使用 DMMN 进行的腈基转移避免了使用有毒试剂和过渡金属,并且在温和的反应条件下发生,即使对于空间位阻非常大的底物也是如此。由定向邻位锂化产生的芳基锂物质的腈基转腈作用使净 CH 氰化成为可能。Thorpe 型亚胺加合物在反应中的中介作用是通过从淬灭反应中分离相应的酮来支持的。计算研究支持亚胺加合物逆向索普碎裂的能量有利性。
  • Anilide derivative, production and use thereof
    申请人:Takeda Chemical Industries, Ltd.
    公开号:US06235771B1
    公开(公告)日:2001-05-22
    This invention is to provide a compound of the formula: wherein R1 is an optionally substituted 5- to 6-membered ring; the ring A is an optionally substituted 6- to 7-membered ring; the ring B is an optionally substituted benzene ring; n is an integer of 1 or 2; Z is a chemical bond or a divalent group; R2 is (1) an optionally substituted amino group in which a nitrogen atom may form a quaternary ammonium, (2) an optionally substituted nitrogen-containing heterocyclic ring group which may contain a sulfur atom or an oxygen atom as ring constituting atoms and wherein a nitrogen atom may form a quaternary ammonium, (3) a group binding through a sulfur atom or (4) a group of the formula:  wherein k is 0 or 1, and when k is 0, a phosphorus atom may form a phosphonium; and R5 and R6 are independently an optionally substituted hydrocarbon group, an optionally substituted hydroxy group or an optionally substituted amino group, and R5 and R6 may bind to each other to form a cyclic group together with the adjacent phosphorus atom, or a salt thereof , which is useful for antagonizing CCR5 and also for the prevention and treatment of infectious disease of HIV.
    这项发明提供了以下式的化合物: 其中R1是一个可选择取代的5至6成员环;环A是一个可选择取代的6至7成员环;环B是一个可选择取代的苯环;n是1或2的整数;Z是化学键或二价基团;R2是(1)一个可选择取代的氨基团,其中氮原子可以形成季铵盐,(2)一个可选择取代的含氮杂环环基团,可能含有硫原子或氧原子作为环构成原子,其中氮原子可以形成季铵盐,(3)通过硫原子结合的基团或(4)下式的基团: 其中k为0或1,当k为0时,磷原子可以形成磷铵盐;R5和R6分别是可选择取代的碳氢基团、可选择取代的羟基或可选择取代的氨基团,R5和R6可以结合在一起与相邻的磷原子形成环状基团,或其盐,用于拮抗CCR5并用于预防和治疗HIV感染疾病。
查看更多